Reperfusion in acute myocardial infarction

Drug and Therapeutics Bulletin

Volumn 43, Issue 7, 2005, Pages 49-53

[No Author Info available]

Author keywords

[No Author keywords available]

Indexed keywords

ABCIXIMAB; ACETYLSALICYLIC ACID; ALTEPLASE; ANISTREPLASE; CLOPIDOGREL; HEPARIN; PLACEBO; STREPTOKINASE; UROKINASE;

ACUTE HEART INFARCTION; ARTICLE; BLOOD CLOT LYSIS; CLINICAL TRIAL; CORONARY ARTERY BLOOD FLOW; DEATH; HEALTH SERVICE; HEART ARRHYTHMIA; HEART FAILURE; HEART INJURY; HEART MUSCLE INJURY; HEART MUSCLE REPERFUSION; HEART SURGERY; HUMAN; HYPERTENSION; META ANALYSIS; MORBIDITY; PERCUTANEOUS CORONARY INTERVENTION; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PROGNOSIS; RESUSCITATION; STROKE; SYSTEMATIC REVIEW; THROMBOCYTOPENIA; TREATMENT CONTRAINDICATION; UNITED KINGDOM;

EID: 22144491520     PISSN: 00126543     EISSN: None     Source Type: Journal    
DOI: 10.1136/dtb.2005.43749     Document Type: Article

References (31)

1. Hartwell D et al. Clinical effectiveness and cost-effectiveness of immediate angioplasty for acute myocardial infarction: systematic review and economic evaluation. Health Technol Assess 2005; 9 (17).
2. The GUSTO angiographic investigators. The effects of tissue plasminogen activator, streptokinase, or both on coronary-artery patency, ventricular function, and survival after acute myocardial infarction. N Engl J Med 1993; 329: 1615-22.
3. Zijlstra F et al. A comparison of immediate coronary angioplasty with intravenous streptokinase in acute myocardial infarction. N Engl J Med 1993; 328: 680-4.
4. Chesebro JH et al. Thrombolysis in myocardial infarction (TIMI) trial, phase I: a comparison between intravenous tissue plasminogen activator and intravenous streptokinase. Clinical findings through hospital discharge. Circulation 1987; 76: 142-54.
5. Fath-Ordoubadi F et al. Significance of the thrombolysis in myocardial infarction scoring system in assessing infarct-related artery reperfusion and mortality rates in acute myocardial infarction. Am Heart J 1997; 134: 62-8.
6. Fibrinolytic Therapy Trialists' (FTT) Collaborative Group. Indications for fibrinolytic therapy in suspected acute myocardial infarction: collaborative overview of early mortality and major morbidity results from all randomised trials of more than 1000 patients. Lancet 1994; 343: 311-22.
7. Chen Z, 2005. COMMIT/CCS-2: Clopidogrel and metoprolol in myocardial infarction trial/second Chinese cardiac study - The clopidogrel arm [online]. Available: http://www.medscape.com/viewarticle/501637 [Accessed 16 June 2005].
8. DH Coronary Heart Disease Policy Team, 2005. Leading the way progress report 2005. The Coronaly Heart Disease National Service Framework [online]. Available: http://www.dh.gov.uk/assetRoot/04/10/52/82/04105282.pdf [Accessed 16 June 2005].
9. Morrison LJ et al. Mortality and prehospital thrombolysis for acute myocardial infarction. A meta-analysis. JAMA 2000; 283: 2686-92.
10. French JK et al. Prospective evaluation of eligibility for thrombolytic therapy in acute myocardial infarction. BMJ 1996; 312: 1637-41.
11. Simes RJ et al. Link between the angiographic substudy and mortality outcomes in a large randomized trial of myocardial reperfusion. Importance of early and complete infarct artery reperfusion. Circulation 1995; 91: 1923-8.
12. Armstrong PW et al. Acute coronary syndromes in the GUSTO-IIb trial: prognostic insights and impact of recurrent ischemia. Circulation 1998; 98: 1860-8.
13. Nunn CM et al. Long-term outcome after primary angioplasty: report from the primary angioplasty in myocardial infanction (PAMI-I) trial. J Am Coll Cardiol 1999; 33: 640-6.
14. The Global Use of Strategies to Open Occluded Coronary Arteries (GUSTO III) Investigators. A comparison of reteplase with alteplase for acute myocardial infarction. N Engl J Med 1997; 337: 1118-23.
15. Silber S et al. Guidelines for percutaneous coronary interventions. The task force for percutaneous coronary interventions of the European Society of Cardiology. Eur Heart J 2005; 26: 804-47.
16. Keeley EC et al. Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomised trials. Lancet 2003; 361: 13-20.
17. Grines CL et al. Fibrinolytic therapy: is it a treatment of the past? Circulation 2003; 107: 2538-42.
18. Ludman PF, 2004. BCIS audit returns adult interventional procedures 2003 [online]. Available: http://www.bcis.org.uk/resources/documents/returns2003.ppt#1 [Accessed 16 June 2005].
19. Bouzamondo A et al. Revascularization strategies in acute myocardial infarction: a meta-analysis. Int J Clin Pharmacol Ther 2004; 42: 663-71.
20. De Luca G et al. Abciximab as adjunctive therapy to reperfusion in acute ST-segment elevation myocardial infarction. A meta-analysis of randomized trials. JAMA 2005; 293: 1759-65.
21. Widimský P et al. Long distance transport for primary angioplasty vs immediate thrombolysis in acute myocardial infarction. Final results of the randomized national multicentre trial - PRAGUE-2. Eur Heart J 2003; 24: 94-104.
22. Schömig A et al. Mechanical reperfusion in patients with acute myocardial infarction presenting more than 12 hours from symptom onset. A randomized controlled trial. JAMA 2005; 293: 2865-72.
23. Dalby M et al. Transfer for primary angioplasty versus immediate thrombolysis in acute myocardial infarction: a meta-analysis. Circulation 2003; 108: 1809-14.
24. Nallamothu BK, Bates ER. Percutaneous coronary intervention versus fibrinolytic therapy in acute myocardial infarction: is timing (almost) everything? Am J Cardiol 2003; 92: 824-6.
25. Montalescot G et al, 2004. Recommendations on percutaneous coronary intervention for the reperfusion of acute ST elevation myocardial infarction [online]. Available: http://heart.bmjjournals.com/cgi/content/full/90/6/e37 [Accessed 16 June 2005].
26. Antman EM et al. ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction: executive summary: a report of the ACC/AHA Task Force on Practice Guidelines (Committee to Revise the 1999 Guidelines on the Management of Patients With Acute Myocardial Infarction). Circulation 2004; 110: 588-636.
27. Sutton AG et al. A randomized trial of rescue angioplasty versus a conservative approach for failed fibrinolysis in ST-segment elevation myocardial infarction. The Middlesbrough Early Revascularization to Limit INfarction (MERLIN) trial. J Am Coll Cardiol 2004; 44: 287-96.
28. Gershlick A, 2004. REACT: Rescue angioplasty versus conservative therapy of repeat thrombolysis [online abstract]. Available: http://ww.medscape.com/viewarticle/493995?src=search [Accessed 16 June 2005].
29. McLellan CS et al. Current reperfusion strategies for ST elevation myocardial infarction: a Canadian perspective. Can J Cardiol 2004; 20: 525-33.
30. Ross AM et al. A randomized trial comparing primary angioplasty with a strategy of short-acting thrombolysis and immediate planned rescue angioplasty in acute myocardial infarcfion: the PACT trial. J Am Coll Cardiol 1999; 34: 1954-62.
31. Widimský P et al. Multicentre randomized trial comparing transport to primary angioplasty vs immediate thrombolysis vs combined strategy for patients with acute myocardial infarction presenting to a community hospital without a catheterization laboratory: The PRAGUE study. Eur Heart J 2000; 21: 823-31.